NO20074618L - Metode for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)-etoksy)propyl)azetidin-3-ol eller salter derav - Google Patents
Metode for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)-etoksy)propyl)azetidin-3-ol eller salter deravInfo
- Publication number
- NO20074618L NO20074618L NO20074618A NO20074618A NO20074618L NO 20074618 L NO20074618 L NO 20074618L NO 20074618 A NO20074618 A NO 20074618A NO 20074618 A NO20074618 A NO 20074618A NO 20074618 L NO20074618 L NO 20074618L
- Authority
- NO
- Norway
- Prior art keywords
- benzothiophen
- azetidin
- ethoxy
- propyl
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Fremgangsmåte for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)etoksy)propyl)azetidin-3-ol, eller salter derav, som omfatter anvendelse av en utgangsforbindelse som er et (fenyltio)eddiksyre-derivat, eller salter derav, representert ved den generelle formel: hvor X1 representerer et halogenatom, er anvendelig som en sikker fremgangsmåte for storskala-produksjon av 1-(3-(2-(1-benzotiofen-5-yl)etoksy)propyl)azetidin-3-ol, eller salter derav, som er anvendelige som et legemiddel mot sykdommer i det sentrale og perifere nervesystem.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005090831 | 2005-03-28 | ||
JP2005174738 | 2005-06-15 | ||
JP2005206808 | 2005-07-15 | ||
JP2005230666 | 2005-08-09 | ||
PCT/JP2006/306127 WO2006104088A1 (ja) | 2005-03-28 | 2006-03-27 | 1-(3-(2-(1-ベンゾチオフェン-5-イル)エトキシ)プロピル)アゼチジン-3-オールまたはその塩の製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20074618L true NO20074618L (no) | 2007-10-25 |
NO340071B1 NO340071B1 (no) | 2017-03-06 |
Family
ID=37053344
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20074618A NO340071B1 (no) | 2005-03-28 | 2007-09-12 | Propionsyreester-derivat |
NO20161418A NO340366B1 (no) | 2005-03-28 | 2016-09-07 | Metode for fremstilling av 3-(2-(1-benzotiofen-5-yl)etoksy)propionsyre eller salter derav |
NO20161419A NO340420B1 (no) | 2005-03-28 | 2016-09-07 | Metode for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)-etoksy)propyl)azetidin-3-ol eller salter derav |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20161418A NO340366B1 (no) | 2005-03-28 | 2016-09-07 | Metode for fremstilling av 3-(2-(1-benzotiofen-5-yl)etoksy)propionsyre eller salter derav |
NO20161419A NO340420B1 (no) | 2005-03-28 | 2016-09-07 | Metode for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)-etoksy)propyl)azetidin-3-ol eller salter derav |
Country Status (22)
Country | Link |
---|---|
US (2) | US7951963B2 (no) |
EP (4) | EP1864978A4 (no) |
JP (1) | JP5031554B2 (no) |
KR (2) | KR101337382B1 (no) |
CN (1) | CN101151257B (no) |
AT (2) | ATE546443T1 (no) |
AU (1) | AU2006229271B2 (no) |
BR (1) | BRPI0609496C8 (no) |
CA (2) | CA2600381C (no) |
CY (3) | CY1112956T1 (no) |
DK (2) | DK2248809T3 (no) |
ES (3) | ES2380443T3 (no) |
IL (2) | IL186044A (no) |
MX (1) | MX2007011938A (no) |
NO (3) | NO340071B1 (no) |
NZ (2) | NZ583580A (no) |
PL (3) | PL2210884T3 (no) |
PT (3) | PT2210884E (no) |
SG (1) | SG155251A1 (no) |
SI (3) | SI2348022T1 (no) |
WO (1) | WO2006104088A1 (no) |
ZA (1) | ZA200708262B (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0213393B8 (pt) | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
EP1864978A4 (en) * | 2005-03-28 | 2009-07-01 | Toyama Chemical Co Ltd | PROCESS FOR PRODUCING 1- (3- (2- (1-BENZOTHIOPHEN-5-YL) -ETHOXY) PROPYL) AZETIDIN-3-OL OR ITS SALTS |
JP4902247B2 (ja) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体 |
US10022352B2 (en) | 2006-04-07 | 2018-07-17 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
US7645789B2 (en) | 2006-04-07 | 2010-01-12 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
HUE036165T2 (hu) | 2006-04-07 | 2018-06-28 | Vertex Pharma | ATP-kötõ kazetta transzportereinek modulátorai |
ATE491705T1 (de) * | 2006-08-04 | 2011-01-15 | Toyama Chemical Co Ltd | Verstärker der aktivität von proteinkinase c, enthaltend ein alkyletherderivat oder ein salz davon |
US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
JP5592205B2 (ja) * | 2009-09-03 | 2014-09-17 | 富山化学工業株式会社 | (1−ベンゾチオフェン−5−イル)酢酸またはその塩の製造法 |
JP5763313B2 (ja) * | 2009-09-03 | 2015-08-12 | 富山化学工業株式会社 | 2−(1−ベンゾチオフェン−5−イル)エタノールの製造法 |
US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
KR20130056244A (ko) * | 2010-04-22 | 2013-05-29 | 버텍스 파마슈티칼스 인코포레이티드 | 시클로알킬카르복스아미도-인돌 화합물의 제조 방법 |
JP6004307B2 (ja) * | 2010-07-26 | 2016-10-05 | 富山化学工業株式会社 | 3−(2−(1−ベンゾチオフェン−5−イル)エトキシ)プロピオン酸の塩またはその水和物およびその製造法 |
KR101999939B1 (ko) | 2011-03-02 | 2019-07-15 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 아릴- 및 헤테로아릴아세트산 유도체의 제조 방법 |
CN103842066B (zh) | 2011-09-30 | 2016-08-24 | 日本化成株式会社 | 聚合性无机颗粒分散剂、含有该聚合性无机颗粒分散剂的无机有机复合颗粒以及无机有机树脂复合材料 |
US9872914B2 (en) | 2012-02-22 | 2018-01-23 | Toyama Chemical Co., Ltd. | Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof |
WO2014014841A1 (en) | 2012-07-16 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof |
WO2015115582A1 (ja) | 2014-01-31 | 2015-08-06 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤 |
PL3925607T3 (pl) | 2014-04-15 | 2023-10-30 | Vertex Pharmaceuticals Incorporated | Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa |
CN109526218B (zh) * | 2016-03-31 | 2021-07-06 | 富士胶片富山化学株式会社 | 5-溴甲基-1-苯并噻吩的制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ208444A (en) | 1983-06-20 | 1987-08-31 | Merck & Co Inc | 2-thiophene derivatives and pharmaceutical compositions |
ZA844616B (en) | 1983-06-20 | 1986-02-26 | Merck & Co Inc | 2-sulfamoylbenzo(b)thiophene derivatives for the treatment of elevated intraocular pressure |
US4668697A (en) * | 1983-10-31 | 1987-05-26 | Merck & Co., Inc. | Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor |
CH673100A5 (no) | 1987-08-10 | 1990-02-15 | Josef Paul Huser | |
JPH04182463A (ja) | 1990-11-17 | 1992-06-30 | Sumitomo Seika Chem Co Ltd | ハロゲノチオフェノール類およびその誘導体の製造方法 |
JPH05140086A (ja) | 1991-09-26 | 1993-06-08 | Sumitomo Seika Chem Co Ltd | ハロゲノチオフエノールの製造方法および精製方法 |
JPH05178816A (ja) | 1991-12-28 | 1993-07-20 | Sumitomo Seika Chem Co Ltd | ハロゲノチオフェノールの製造方法 |
JP2641363B2 (ja) | 1992-04-22 | 1997-08-13 | 三共株式会社 | 新規なフェネチルアルコール及びその製法 |
GB9404775D0 (en) | 1994-03-11 | 1994-04-27 | Payne P P Ltd | Improvements in or relating to article tagging |
JPH08143533A (ja) | 1994-11-24 | 1996-06-04 | Sumitomo Seika Chem Co Ltd | ハロチオフェノール類の製造方法 |
JPH1043967A (ja) | 1996-08-06 | 1998-02-17 | Calsonic Corp | カシメ装置 |
JP4245668B2 (ja) | 1997-03-31 | 2009-03-25 | 富山化学工業株式会社 | 2−(ベンゾ〔b〕チオフェン−5−イル)−2−ヒドロキシ酢酸誘導体もしくはその光学活性体またはそれらの塩の製造法 |
GB9706574D0 (en) | 1997-04-01 | 1997-05-21 | Zeneca Ltd | Cyano substituted cycloalkanes |
JPH1112238A (ja) | 1997-06-23 | 1999-01-19 | Kao Corp | 1−(β−ヒドロキシエチル)−2,5−ジアミノベンゼン又はその塩の製造法 |
JPH1143455A (ja) | 1997-07-25 | 1999-02-16 | Mitsubishi Chem Corp | ハロゲン化アルコールの製造方法 |
AU1506499A (en) | 1997-12-12 | 1999-07-05 | Toyama Chemical Co. Ltd. | Alkyl ether derivatives or salts thereof and calcium antagonists containing the same |
DE69810625T2 (de) | 1998-10-07 | 2003-11-27 | St Microelectronics Srl | Leistungsübertragungssteueurung in Sperrwandler durch lastabhängige Austastmodulation |
JP4182463B2 (ja) | 2000-07-19 | 2008-11-19 | 富士電機デバイステクノロジー株式会社 | 磁気ディスク評価装置およびその方法 |
WO2002100850A1 (fr) | 2001-06-08 | 2002-12-19 | Kuraray Co., Ltd. | Procedes de preparation de composes heterocycliques |
BRPI0213393B8 (pt) | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
ZA200508166B (en) * | 2003-04-17 | 2007-03-28 | Toyama Chemical Co Ltd | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
JP2005012291A (ja) | 2003-06-17 | 2005-01-13 | National Institute Of Information & Communication Technology | Tv会議用モバイル動画通信端末 |
US20050032873A1 (en) * | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
WO2005019200A2 (en) * | 2003-08-14 | 2005-03-03 | Icos Corporation | Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
EP1864978A4 (en) | 2005-03-28 | 2009-07-01 | Toyama Chemical Co Ltd | PROCESS FOR PRODUCING 1- (3- (2- (1-BENZOTHIOPHEN-5-YL) -ETHOXY) PROPYL) AZETIDIN-3-OL OR ITS SALTS |
ZA200808728B (en) | 2006-04-26 | 2010-01-27 | Toyama Chemical Co Ltd | Neurogenesis inducer or neuropathy Therapeutic agent comprising alkyl ether derivative or salt thereof |
-
2006
- 2006-03-27 EP EP06730075A patent/EP1864978A4/en not_active Withdrawn
- 2006-03-27 BR BRPI0609496A patent/BRPI0609496C8/pt active IP Right Grant
- 2006-03-27 KR KR1020127032936A patent/KR101337382B1/ko active IP Right Grant
- 2006-03-27 CA CA2600381A patent/CA2600381C/en active Active
- 2006-03-27 AU AU2006229271A patent/AU2006229271B2/en active Active
- 2006-03-27 EP EP11002265A patent/EP2348022B1/en active Active
- 2006-03-27 ES ES10002020T patent/ES2380443T3/es active Active
- 2006-03-27 AT AT10002020T patent/ATE546443T1/de active
- 2006-03-27 CA CA2799659A patent/CA2799659C/en active Active
- 2006-03-27 SI SI200631556T patent/SI2348022T1/sl unknown
- 2006-03-27 JP JP2007510482A patent/JP5031554B2/ja active Active
- 2006-03-27 NZ NZ583580A patent/NZ583580A/en unknown
- 2006-03-27 DK DK10007872.4T patent/DK2248809T3/da active
- 2006-03-27 CN CN2006800102653A patent/CN101151257B/zh active Active
- 2006-03-27 MX MX2007011938A patent/MX2007011938A/es active IP Right Grant
- 2006-03-27 US US11/909,809 patent/US7951963B2/en active Active
- 2006-03-27 PL PL10002020T patent/PL2210884T3/pl unknown
- 2006-03-27 ES ES11002265T patent/ES2398934T3/es active Active
- 2006-03-27 SG SG200905724-1A patent/SG155251A1/en unknown
- 2006-03-27 WO PCT/JP2006/306127 patent/WO2006104088A1/ja active Application Filing
- 2006-03-27 EP EP10002020A patent/EP2210884B1/en active Active
- 2006-03-27 DK DK10002020.5T patent/DK2210884T3/da active
- 2006-03-27 PT PT10002020T patent/PT2210884E/pt unknown
- 2006-03-27 ZA ZA200708262A patent/ZA200708262B/xx unknown
- 2006-03-27 NZ NZ561672A patent/NZ561672A/en unknown
- 2006-03-27 KR KR1020077024039A patent/KR101283930B1/ko active IP Right Grant
- 2006-03-27 SI SI200631324T patent/SI2210884T1/sl unknown
- 2006-03-27 PT PT10007872T patent/PT2248809E/pt unknown
- 2006-03-27 PL PL10007872T patent/PL2248809T3/pl unknown
- 2006-03-27 ES ES10007872T patent/ES2384312T3/es active Active
- 2006-03-27 PL PL11002265T patent/PL2348022T3/pl unknown
- 2006-03-27 SI SI200631383T patent/SI2248809T1/sl unknown
- 2006-03-27 EP EP10007872A patent/EP2248809B1/en active Active
- 2006-03-27 AT AT10007872T patent/ATE557020T1/de active
- 2006-03-27 PT PT110022654T patent/PT2348022E/pt unknown
-
2007
- 2007-09-12 NO NO20074618A patent/NO340071B1/no unknown
- 2007-09-18 IL IL186044A patent/IL186044A/en active IP Right Grant
-
2011
- 2011-01-06 US US12/985,616 patent/US8273902B2/en active Active
- 2011-07-21 IL IL214245A patent/IL214245A/en active IP Right Grant
-
2012
- 2012-05-08 CY CY20121100434T patent/CY1112956T1/el unknown
- 2012-06-27 CY CY20121100566T patent/CY1112885T1/el unknown
-
2013
- 2013-01-25 CY CY20131100075T patent/CY1113571T1/el unknown
-
2016
- 2016-09-07 NO NO20161418A patent/NO340366B1/no unknown
- 2016-09-07 NO NO20161419A patent/NO340420B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20161418A1 (no) | Metode for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)-etoksy)propyl)azetidin-3-ol eller salter derav | |
WO2006062673A3 (en) | Processes for separating metals from metal salts | |
WO2008132314A3 (fr) | Procede de synthese de nanoparticules metalliques cubiques en presence de deux reducteurs | |
TW200726756A (en) | Process for the synthesis of organic compounds | |
UA91495C2 (en) | Method for preparing organosilanes | |
MX2011009127A (es) | Nicotinamidas sustituidas como moduladores de kcnq2/3. | |
BRPI0503815A (pt) | processo para produção de mercaptoorganil (alcoxissilano) | |
HK1152292A1 (en) | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)- cyclopropanecarboxylic acid | |
MX2007013872A (es) | Procedimiento para la produccion de 4-bifenililazetidina-2-onas. | |
WO2006120254A3 (de) | Verfahren zur herstellung eines zahnersatzteils und ein derart hergestelltes zahnersatzteil sowie rohling zur herstellung eines zahnersatzteils | |
ZA201006792B (en) | Process for the synthesis of ethynylcylopropane | |
SG136920A1 (en) | Process for producing methionine | |
AR077457A1 (es) | Intermediarios y proceso de preparacion de 4-(acetilamino)-3-[(4-cloro-fenil)tio]-2-metil-1h-indol-1-acetico | |
BR112012015708A2 (pt) | novo processo para produção de 4-aminobut-2-enolidas a partir de 4-alcoxifuran-2 (5h) -ona ou 4-arilalcoxfuran-2 (5h) -ona | |
JP2006223962A5 (no) | ||
EP2077259A4 (en) | PROCESS FOR THE PRODUCTION OF 2,6-DIMETHYL-1-NAPHTHALDEHYDE | |
MX2009001508A (es) | Un proceso novedoso para preparar ester de acido 3-amino-5-fluoro-4-dialcoxipentanoico. | |
WO2008024492A3 (en) | Indolinone phenylaminopropanol derivatives and process for the preparation thereof | |
EP2226310A4 (en) | PROCESS FOR PRODUCING 2- (1-HYDROXYALKYL) CYCLOALCANONE | |
HU0501156D0 (en) | Process for the production of 15-alpha-hydroxylevodion by bioconversion | |
UA36363U (ru) | Шихта для изготовления огнеупорного материала |